MLKL

Jinglei Sun1, Wenting Wu1,2, Yi Wang1

  • 1Department of Pharmacology, Hebei Medical University, The Key Laboratory of New Drug Pharmacology and Toxicology, Hebei Province, The Key Laboratory of Neural and Vascular Biology, Ministry of Education, 361 East Zhongshan Road, Shijiazhuang, 050017, Hebei, China.

Inflammation
|April 8, 2025
PubMed
概括

亡,细胞死亡途径,驱动免疫相关的心肌炎. 阻断混合基因酶域样蛋白 (MLKL) 在体外和体内保护心脏细胞免受免疫损伤,这表明心肌炎的治疗标.